Formation Bio has appointed Michael Ehlers as chief scientific officer and head of research and development. Ehlers previously served as CEO and president of Ascidian Therapeutics, a company he founded.
But all work and no play can make for a dull chief scientific officer and R&D chief.
Also Read
- ESC Issues First Dedicated Guidelines for Managing Cardiovascular Disease in Patients with Chronic Kidney Disease
- FDA Reports 17 E. coli Cases Linked to Contaminated Frozen Blueberries in Multi-State Recall
- You Can Argue With a Machine, Doctor
- Mind chief admits mental health sector has failed to address violence risk